Evidence map›Paper›PMID 30511397›Full record

ArticleThe Journal of pathology2019

Interferon-γ directly induces gastric epithelial cell death and is required for progression to metaplasia.

Luciana H Osaki, Kevin A Bockerstett, Chun F Wong, Eric L Ford, Blair B Madison, Richard J DiPaolo, Jason C Mills

Abstract read
In one paragraph

Article in The Journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Autoimmune gastritis: emerging insights and clinical management.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Recent advances in spasmolytic polypeptide expressing metaplasia research.World journal of gastrointestinal oncology · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Inflammatory factors collaboratively linkFrontiers in immunology · 2025
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. World journal of clinical cases · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Luciana H OsakiDepartment of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.ORCID 0000-0003-0665-7567
Kevin A BockerstettDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.ORCID 0000-0002-5010-4970
Chun F WongDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
Eric L FordDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
Blair B MadisonDepartment of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Richard J DiPaoloDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
Jason C MillsDepartment of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Saint Louis University · ESWashington University in St. Louis · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUSR01DK094989 · NIDDK · WASHINGTON UNIVERSITY · PI Jason C Mills · 2012 to 2026
$6.1M
MECHANISMS OF CHIEF CELL DEDIFFERENTIATIONR01DK105129 · NIDDK · WASHINGTON UNIVERSITY · PI Jason C Mills · 2015 to 2026
$5.4M
The Role of EBI3 in Regulating Gastritis and Gastric CarcinogenesisR01DK110406 · NIDDK · SAINT LOUIS UNIVERSITY · PI DIPAOLO, RICHARD J · 2016 to 2020
$2.3M
Role of LIN28B in the regulation of intestinal epithelial growthK01DK093885 · NIDDK · WASHINGTON UNIVERSITY · PI MADISON, BLAIR BERNARD · 2012 to 2016
$647k
The Role of Epstein-Barr Virus-Induced Gene 3 (EBI3) in Preventing Gastric Atrophy and MetaplasiaF30DK118873 · NIDDK · SAINT LOUIS UNIVERSITY · PI BOCKERSTETT, KEVIN A · 2018 to 2021
$157k
LET-7 MICRORNA REPRESSION OF STEM CELL COMPETITION AND CLONAL EXPANSIONR03DK108764 · NIDDK · WASHINGTON UNIVERSITY · PI MADISON, BLAIR BERNARD · 2016 to 2017
$153k
NIDDK NIH HHS F30 DK118873NIDDK NIH HHS K01 DK093885NIDDK NIH HHS P30 DK052574NIDDK NIH HHS R01 DK094989NIDDK NIH HHS R01 DK105129NIDDK NIH HHS R01 DK110406NIDDK NIH HHS R03 DK108764
6 · The paper itself

Abstract

Chronic inflammation of the gastric mucosa, often caused by autoimmune gastritis and/or infection with Helicobacter pylori, can lead to atrophy of acid-secreting parietal cells with metaplasia of remaining cells. The histological pattern marks a critical step in the progression from chronic gastritis to gastric cancer, yet underlying mechanism(s) of inflammation-induced cell death of gastric epithelial cells are poorly understood. We investigated direct effects of a type 1 cytokine associated with autoimmunity and infection, interferon-γ (IFN-γ), on gastric epithelial cells. IFN-γ was applied to three-dimensional organoid cultures of gastric epithelial cells derived from gastric corpus gland (gastroids) of control and IFN-γ receptor-deficient mice. Gastroids were also treated with supernatants from activated immune cells isolated from a mouse model of autoimmune-mediated atrophic gastritis (TxA23) with and without IFN-γ expression. Finally, histopathological analysis of atrophy and metaplasia severity was performed in TxA23 mice and compared to TxA23 × Ifng

Indexed as

AnimalsAtrophyCell DeathCell Transformation, NeoplasticDisease ProgressionEpithelial CellsGastric MucosaGastritisInterferon-gammaMetaplasiaMice, Inbred BALB CMice, Inbred C57BLParietal Cells, GastricStomach NeoplasmsTumor Cells, CulturedInterferon-gammaatrophic gastritisinflammationpaligenosisspasmolytic polypeptide-expressing metaplasia (SPEM)

Identifiers

PMID30511397
PMCPMC6402979
OpenAlexW2903374927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.